InvestorsHub Logo
Followers 0
Posts 121
Boards Moderated 0
Alias Born 04/06/2020

Re: None

Wednesday, 06/12/2024 9:45:46 AM

Wednesday, June 12, 2024 9:45:46 AM

Post# of 36606
News: Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat Long COVID

Jun 12, 2024

https://revivethera.com/2024/06/revive-therapeutics-provides-update-on-fda-type-c-meeting-for-clinical-study-of-bucillamine-to-treat-long-covid/